Trinity Biotech PLC
NASDAQ:TRIB
Trinity Biotech PLC
Cash Equivalents
Trinity Biotech PLC
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Trinity Biotech PLC
NASDAQ:TRIB
|
Cash Equivalents
$5.8m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-10%
|
|
Medtronic PLC
NYSE:MDT
|
Cash Equivalents
$1.3B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-1%
|
|
STERIS plc
NYSE:STE
|
Cash Equivalents
$207m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
3%
|
See Also
What is Trinity Biotech PLC's Cash Equivalents?
Cash Equivalents
5.8m
USD
Based on the financial report for Mar 31, 2024, Trinity Biotech PLC's Cash Equivalents amounts to 5.8m USD.
What is Trinity Biotech PLC's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
-10%
Over the last year, the Cash Equivalents growth was 64%. The average annual Cash Equivalents growth rates for Trinity Biotech PLC have been -44% over the past three years , -28% over the past five years , and -10% over the past ten years .